Recent 8-K filings for GTHP

• March 10, 2026, 7:59 PM ET other material materiality 0.35 neutral item 1.01item 3.02item 8.01item 9.01 ◈ Equity Issuances

  Guided Therapeutics completes warrant exchange; issues 4.825M shares for $980K cash

  Holders of 4.825M eligible warrants (22.7% of total) tendered; exchanged for restricted common stock at reduced exercise prices.

• December 23, 2024, 6:59 PM ET other material materiality 0.50 neutral item 1.01item 9.01

  Guided Therapeutics raises $535K in private placement; issues shares and warrants at $0.13/unit

  Gross proceeds of $535,000 from sale of 4,115,386 shares and warrants to purchase same number.

• September 27, 2024, 7:59 PM ET other material materiality 0.50 neutral item 1.01item 9.01

  Guided Therapeutics raises $300,000 in private placement of common stock and warrants

  Gross proceeds of $300,000 from sale of 3,333,335 shares and warrants to purchase 3,333,335 shares.

• March 9, 2023, 6:59 PM ET leadership materiality 0.55 neutral item 5.02 ◈ executive_change ×3

  Guided Therapeutics CEO Gene Cartwright retires; Mark Faupel appointed as successor

  Gene Cartwright retired as President, CEO, and Board member effective March 3, 2023; no disagreement cited.

• September 15, 2022, 7:59 PM ET other material materiality 0.85 positive item 1.01item 3.02item 8.01item 9.01

  Guided Therapeutics closes $3.3M bridge financing, exchanges Auctus debt, targets FDA study completion

  Raised ~$3.3M via 6.6M shares at $0.50 each, plus four-year warrants for 6.6M shares at $0.50 and 6.6M at $0.65.

• July 29, 2022, 7:59 PM ET other material materiality 0.50 neutral item 3.03item 5.03item 9.01

  Guided Therapeutics cancels previously approved 1-for-20 reverse stock split, renders amendment void

  Certificate of Correction filed July 25, 2022, nullifies December 30, 2021 reverse split amendment ab initio.

• January 7, 2022, 6:59 PM ET other material materiality 0.50 neutral item 3.03item 5.03item 9.01

  Guided Therapeutics approves 1-for-20 reverse stock split; FINRA effective date pending

  Board approved 1-for-20 reverse split on Dec 30, 2021; Certificate of Amendment filed with Delaware.

• September 7, 2021, 7:59 PM ET other material materiality 0.65 positive item 1.01item 8.01item 9.01

  Guided Therapeutics passes regulatory review in China; receives $133K payment from SMI

  Clinical trial at Fudan University approved; trials at 4 centers start Q3 2021.

• July 27, 2021, 7:59 PM ET other material materiality 0.20 neutral item 5.07

  Guided Therapeutics shareholders approve reverse split and charter changes at annual meeting

  All seven proposals approved at July 22, 2021 annual meeting.

• July 7, 2021, 7:59 PM ET other materiality 0.05 neutral item 8.01

  Guided Therapeutics schedules 2021 Annual Meeting for July 22; proposal deadline July 16

  Annual Meeting will be held July 22, 2021 at 10:00 a.m. local time.

Executive changes

Materiality & sentiment trend

Max materiality 0.85 · Median 0.50 · Most common event other_material

2 positive 0 negative 8 neutral

source · GTHP on sec.gov